Hunan To Trial Publicizing Blacklisted Pharma Practitioners
This article was originally published in PharmAsia News
Executive Summary
Hunan FDA will publicize blacklisted pharma on its Website for two years under its recently launched drug safety guidelines, keeping a public archive.